Stifel Nicolaus started coverage on shares of Tempus AI (NASDAQ:TEM – Free Report) in a research report report published on Tuesday, Marketbeat Ratings reports. The firm issued a buy rating and a $45.00 price target on the stock.
Other equities analysts have also issued reports about the stock. Loop Capital assumed coverage on shares of Tempus AI in a report on Tuesday. They issued a buy rating and a $48.00 target price on the stock. TD Cowen assumed coverage on shares of Tempus AI in a report on Tuesday. They issued a buy rating and a $50.00 target price on the stock. Needham & Company LLC assumed coverage on shares of Tempus AI in a report on Tuesday. They issued a buy rating and a $47.00 price objective on the stock. Finally, JPMorgan Chase & Co. assumed coverage on shares of Tempus AI in a report on Tuesday. They issued an overweight rating and a $42.00 price objective on the stock. Nine research analysts have rated the stock with a buy rating, According to data from MarketBeat, Tempus AI has a consensus rating of Buy and an average price target of $45.63.
View Our Latest Analysis on Tempus AI
Tempus AI Stock Performance
About Tempus AI
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
See Also
- Five stocks we like better than Tempus AI
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Top 3 Beverage Stocks: Summer Earnings Reveal Key Trends
- Election Stocks: How Elections Affect the Stock Market
- This Financial Stock’s Earnings Signal a Buying Opportunity
- What Does Downgrade Mean in Investing?
- Social Platform Stock Hits New Highs: Is More Growth Ahead?
Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.